Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Metabolomics reveals a link between homocysteine and lipid metabolism and leukocyte telomere length: the ENGAGE consortium.

van der Spek A, Broer L, Draisma HHM, Pool R, Albrecht E, Beekman M, Mangino M, Raag M, Nyholt DR, Dharuri HK, Codd V, Amin N, de Geus EJC, Deelen J, Demirkan A, Yet I, Fischer K, Haller T, Henders AK, Isaacs A, Medland SE, Montgomery GW, Mooijaart SP, Strauch K, Suchiman HED, Vaarhorst AAM, van Heemst D, Wang-Sattler R, Whitfield JB, Willemsen G, Wright MJ, Martin NG, Samani NJ, Metspalu A, Eline Slagboom P, Spector TD, Boomsma DI, van Duijn CM, Gieger C.

Sci Rep. 2019 Aug 12;9(1):11623. doi: 10.1038/s41598-019-47282-6.

2.

Implementing an Updated "Break the Cycle" Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US "opioid epidemic" Setting.

Des Jarlais D, Uuskula A, Talu A, Barnes DM, Raag M, Arasteh K, Org G, Demarest D, Feelemyer J, Berg H, Tross S.

AIDS Behav. 2019 Sep;23(9):2304-2314. doi: 10.1007/s10461-019-02467-y.

PMID:
30879209
3.

Prevalence of injecting drug use in Estonia 2010-2015: a capture-recapture study.

Raag M, Vorobjov S, Uusküla A.

Harm Reduct J. 2019 Mar 14;16(1):19. doi: 10.1186/s12954-019-0289-3.

4.

Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

Uusküla A, Barnes DM, Raag M, Talu A, Tross S, Des Jarlais DC.

Drug Alcohol Depend. 2018 Jul 1;188:64-70. doi: 10.1016/j.drugalcdep.2018.03.048. Epub 2018 May 8.

PMID:
29754028
5.

Personality traits and escitalopram treatment outcome in major depression.

Aluoja A, Tõru I, Raag M, Eller T, Võhma Ü, Maron E.

Nord J Psychiatry. 2018 Jul;72(5):354-360. doi: 10.1080/08039488.2018.1465590. Epub 2018 Apr 24.

PMID:
29688152
6.

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study.

Uusküla A, Raag M, Vorobjov S, Jarlais DD.

Harm Reduct J. 2018 Mar 5;15(1):10. doi: 10.1186/s12954-018-0215-0.

7.

Cigarette smoking and smoking-attributable diseases among Estonian physicians: a cross-sectional study.

Raag M, Pärna K.

BMC Public Health. 2018 Jan 30;18(1):194. doi: 10.1186/s12889-018-5105-6.

8.

Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia.

Wu J, Crawford FW, Raag M, Heimer R, Uusküla A.

PLoS One. 2017 Nov 2;12(11):e0185711. doi: 10.1371/journal.pone.0185711. eCollection 2017.

9.

The impact of comorbidities on hip fracture mortality: a retrospective population-based cohort study.

Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A.

Arch Osteoporos. 2017 Aug 28;12(1):76. doi: 10.1007/s11657-017-0370-z.

PMID:
28849347
10.

Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.

Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A.

BMC Musculoskelet Disord. 2017 Aug 24;18(1):366. doi: 10.1186/s12891-017-1735-6. No abstract available.

11.

Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial.

Uusküla A, Laisaar KT, Raag M, Lemsalu L, Lõhmus L, Rüütel K, Amico KR; HIV-BRIDGE Study Group.

AIDS Behav. 2018 Jan;22(1):224-233. doi: 10.1007/s10461-017-1859-6.

PMID:
28717981
12.

The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.

Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A.

BMC Musculoskelet Disord. 2017 Jun 5;18(1):243. doi: 10.1186/s12891-017-1606-1. Erratum in: BMC Musculoskelet Disord. 2017 Aug 24;18(1):366.

13.

Association between personality traits and Escitalopram treatment efficacy in panic disorder.

Võhma Ü, Raag M, Tõru I, Aluoja A, Maron E.

Nord J Psychiatry. 2017 Aug;71(6):433-440. doi: 10.1080/08039488.2017.1316772. Epub 2017 May 4.

PMID:
28472591
14.

HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.

Uusküla A, Raag M, Marsh K, Talu A, Vorobjov S, Des Jarlais D.

PLoS One. 2017 Feb 2;12(2):e0170956. doi: 10.1371/journal.pone.0170956. eCollection 2017.

15.

People living with HIV in Estonia: engagement in HIV care in 2013.

Laisaar KT, Raag M, Lutsar I, Uusküla A.

Euro Surveill. 2016 Oct 27;21(43). doi: 10.2807/1560-7917.ES.2016.21.43.30380.

16.

Prospective study of percutaneous tracheostomy: Role of bronchoscopy and surgical technique.

Laisaar T, Jakobson E, Sarana B, Sarapuu S, Vahtramäe J, Raag M.

SAGE Open Med. 2016 Sep 21;4:2050312116670407. eCollection 2016.

17.

Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.

Uusküla A, Raag M, Vorobjov S, Rüütel K, Lyubimova A, Levina OS, Heimer R.

BMC Public Health. 2015 Dec 18;15:1255. doi: 10.1186/s12889-015-2604-6.

18.

Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review.

Laisaar KT, Raag M, Rosenthal M, Uusküla A.

AIDS Patient Care STDS. 2015 May;29(5):288-98. doi: 10.1089/apc.2014.0240. Epub 2015 Apr 6. Review.

19.

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West.

Uusküla A, Raag M, Folch C, Prasad L, Karnite A, van Veen MG, Eritsyan K, Rosinska M, Des Jarlais DC, Wiessing L.

AIDS. 2014 Jul 17;28(11):1657-64. doi: 10.1097/QAD.0000000000000299.

PMID:
25232900
20.

Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia.

Uusküla A, Des Jarlais DC, Raag M, Pinkerton SD, Feelemyer J.

AIDS Care. 2015;27(1):105-11. doi: 10.1080/09540121.2014.940271. Epub 2014 Jul 23.

21.

Regular aquatic exercise for chronic kidney disease patients: a 10-year follow-up study.

Pechter Ü, Raag M, Ots-Rosenberg M.

Int J Rehabil Res. 2014 Sep;37(3):251-5. doi: 10.1097/MRR.0000000000000063.

PMID:
24859430
22.

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia.

Uusküla A, Müürsepp A, Kawai K, Raag M, Jürisson M, Pillsbury M.

BMC Infect Dis. 2013 Jul 3;13:304. doi: 10.1186/1471-2334-13-304.

23.

Incidence of cervical intraepithelial neoplasia in Estonia.

Uusküla A, Raag M, Uppin A, Raud T, Klaar U, Jürisson M, Müürsepp A.

J Low Genit Tract Dis. 2013 Apr;17(2):129-36. doi: 10.1097/LGT.0b013e3182652213.

PMID:
23422640
24.

The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.

Tõru I, Maron E, Raag M, Vasar V, Nutt DJ, Shlik J.

Eur Neuropsychopharmacol. 2013 Jul;23(7):645-52. doi: 10.1016/j.euroneuro.2012.08.011. Epub 2012 Aug 29.

PMID:
22939006
25.

Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.

Uusküla A, Laisaar KT, Raag M, Šmidt J, Semjonova S, Kogan J, Amico KR, Sharma A, Dehovitz J.

AIDS Care. 2012;24(12):1470-9. doi: 10.1080/09540121.2012.672724. Epub 2012 Apr 25.

PMID:
22533736
26.

Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors.

Uusküla A, McMahon JM, Raag M, Silm S, Rüütel K, Talu A, Abel-Ollo K, Ahas R, Des Jarlais DC.

Sex Transm Infect. 2010 Dec;86 Suppl 3:iii79-84. doi: 10.1136/sti.2009.040212.

PMID:
21098060
27.

Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.

Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.

Psychiatry Res. 2010 Jul 30;178(2):342-7. doi: 10.1016/j.psychres.2010.04.003. Epub 2010 May 14.

PMID:
20471107
28.

Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia.

Uusküla A, Johnston LG, Raag M, Trummal A, Talu A, Des Jarlais DC.

J Urban Health. 2010 Mar;87(2):304-317. doi: 10.1007/s11524-009-9427-7. Epub 2010 Feb 4.

Supplemental Content

Support Center